Bonnielin Swenor, an assistant professor of ophthalmology with myopic macular degeneration herself, smiles in a head shot photo.

What Medicine Can Learn From Doctors And Researchers With Disabilities

BY SUSIE NEILSON (Via NPR) Bonnielin Swenor has devoted her life to studying visual impairment in older adults. But for a long time, she didn't often discuss the motivation fueling her work — that she herself has low vision. Swenor, an assistant professor of ophthalmology at the Wilmer Eye Institute at Johns Hopkins University, has myopic [...]

Continue Reading this article ...

A woman wearing headphones smiles as she uses her laptop in the library. A stack of books rests on the desk.

EBSCO Information Services Partners with The Carroll Center for the Blind to Advance User Research and Design

IPSWICH, Mass. (May 16, 2019) — EBSCO Information Services (EBSCO) and The Carroll Center for the Blind today announced a partnership in which the two organizations will work together to improve and enhance the experience across EBSCO products for users with a varying array of disabilities. The Carroll Center for the Blind, based in Newton, [...]

Continue Reading this article ...

premature baby

New therapy for premature babies at risk of blindness

An Oregon doctor is working on a new therapy to make sure retinopathy of prematurity does not destroy a newborn baby’s vision. More and smaller premature babies are surviving than ever before. That’s leading to a rise in the number of cases of retinopathy of prematurity, or ROP. It’s a blinding eye disorder that the […]

Continue Reading this article ...

The Carroll Center for the Blind logo

Hair-Sized Stent Offers Hope For Patients Suffering From Glaucoma

A tiny new device could help prevent a leading cause of blindness. The glaucoma implant is the size of a human hair, and was just approved by the Food and Drug Administration. Glaucoma is dangerous because it doesn’t cause symptoms until you’ve permanently lost vision and as CBS2’s Dr. Max Gomez reported, the device provides […]

Continue Reading this article ...

Research indicates that bionic vision will continue to improve at a rapid pace. Picture: iStock

THE ETHICAL FUTURE OF BIONIC VISION

Article by Max Slattery, University of Melbourne As researchers refine the capabilities of bionic eyes, restoring sight to some blind people may be just around the corner. But what are the ethical implications of ‘artificial’ sight? Curing blindness – at least in some of its many guises – with a prosthetic retina, also known as a […]

Continue Reading this article ...

Cross-section of biodegradable film. Image credit: UCSF

New Drug Delivery Device Treats Glaucoma from Within the Eye

A new drug delivery system could be a crucial development in the fight against glaucoma. The disease currently affects more than 60 million people around the world, making it the second-leading cause of blindness, behind cataracts. That number is expected to increase to 76 million by 2020 and even further to nearly 112 million by […]

Continue Reading this article ...

The Carroll Center for the Blind logo

Trigger for most common form of vision loss discovered

In a major step forward in the battle against macular degeneration, the leading cause of vision loss among the elderly, researchers at the University of Virginia School of Medicine have discovered a critical trigger for the damaging inflammation that ultimately robs millions of their sight. The finding may allow doctors to halt the inflammation early […]

Continue Reading this article ...

The Carroll Center for the Blind logo

After cooking, biofortified corn and eggs retain nutrient needed to prevent blindness

Fortified and biofortified foods are at the forefront of efforts to combat vitamin A deficiency worldwide. But little is known about what influence processing may have on the retention of vitamin A precursors in these foods. Now in a study appearing in ACS Omega, scientists report that a high percentage of these healthful substances—in some […]

Continue Reading this article ...

The Carroll Center for the Blind logo

$1 million price tag in spotlight as gene therapy becomes reality

Spark Therapeutics (ONCE.O), whose Luxturna treatment has been recommended for U.S. approval, told investors last week there was a case for valuing it at more than $1 million per patient, although it has yet to set an actual price. However, the U.S. Institute for Clinical and Economic Review (ICER) said this week “at a placeholder […]

Continue Reading this article ...

The Carroll Center for the Blind logo

Researchers predict greater need for low vision services

The exponential growth in the prevalence of low vision with age reflects the increased risk of vision loss as a result of age-related eye disease each year, according to researchers utilizing data from the National Health and Nutrition Examination Survey. The 6,016 survey participants ranged from younger than 18 years to older than 45 years. […]

Continue Reading this article ...